TRIMETAZIDINE EG 35 mg, modified-release film-coated tablet 60 tablets
Active ingredients: Trimetazidine dihydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Modified-release film-coated tablet60 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TRIMETAZIDINE EG 35 mg, comprimé pelliculé à libération modifiée
- Pharmaceutical form
- comprimé pelliculé à libération modifiée
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 60 comprimé(s)
- Marketing authorisation holder
- LES LABORATOIRES SERVIER
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 15 Dec 2010
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60154024CIP73799707CIP133400937997072Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DICHLORHYDRATE DE TRIMÉTAZIDINEcomprimé | 35 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.